{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:20:18Z","timestamp":1785280818803,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.gofs.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T08:43:13Z","timestamp":1713256993000},"page":"657-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u00c9tat des lieux sur les anti-IL-1\u00a0chez la femme enceinte"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7510-9364","authenticated-orcid":false,"given":"Valentine","family":"Faure-Bardon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Beghin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Coulm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vauzelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2024.04.004_bib0180","unstructured":"Anakinra\u00a0: substance active \u00e0 effet th\u00e9rapeutique. VIDAL n.d. https:\/\/www.vidal.fr\/medicaments\/substances\/anakinra-21892.html (accessed January 5, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0185","unstructured":"Canakinumab\u00a0: substance active \u00e0 effet th\u00e9rapeutique. VIDAL n.d. https:\/\/www.vidal.fr\/medicaments\/substances\/canakinumab-23224.html (accessed January 5, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0190","unstructured":"PNDS\u00a0\u2013\u00a0syndromes p\u00e9riodiques associ\u00e9s \u00e0 la cryopyrine (CAPS) 2013. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2013-05\/pnds_-_syndromes_periodiques_associes_a_la_cryopyrine_caps_2013-05-15_15-23-40_118.pdf."},{"key":"10.1016\/j.gofs.2024.04.004_bib0195","unstructured":"Orphanet\u00a0: maladie auto-inflammatoire associ\u00e9e \u00e0 NLRP3\u00a0n.d. https:\/\/www.orpha.net\/fr\/disease\/detail\/208650."},{"key":"10.1016\/j.gofs.2024.04.004_bib0200","unstructured":"Fiche info \u2013\u00a0KINERET 100\u00a0mg\/0,67\u00a0ml, solution injectable en seringue pr\u00e9remplie\u00a0\u2013 base de donn\u00e9es publique des m\u00e9dicaments n.d. https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=60663231 (accessed March 27, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0205","unstructured":"KINERET (anakinra), immunosuppresseur. Haute Aut Sant\u00e9 n.d. https:\/\/www.has-sante.fr\/jcms\/c_1765197\/fr\/kineret-anakinra-immunosuppresseur (accessed December 1, 2023)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0210","unstructured":"PNDS\u00a0\u2013\u00a0fi\u00e8vre m\u00e9diterran\u00e9enne familiale 2013. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2013-02\/pnds_-_fievre_mediterraneenne_familiale.pdf."},{"key":"10.1016\/j.gofs.2024.04.004_bib0215","unstructured":"Maladie de Still de l\u2019adulte. Haute Aut Sant\u00e9 n.d. https:\/\/www.has-sante.fr\/jcms\/c_2867360\/fr\/maladie-de-still-de-l-adulte (accessed January 5, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0220","unstructured":"Dictionnaire m\u00e9dical de l\u2019Acad\u00e9mie de M\u00e9decine. D\u00e9finition Interleukine-1\u00a0n.d. https:\/\/www.academie-medecine.fr\/le-dictionnaire\/index.php?q=interleukine-1 (accessed March 11, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12444","article-title":"Transplacental transfer of interleukin-1\u00a0receptor agonist and antagonist following maternal immune activation","volume":"75","author":"Girard","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10875-017-0389-3","article-title":"Placental transfer of canakinumab in a patient with muckle-wells syndrome","volume":"37","author":"Egawa","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0235","unstructured":"ILARIS\u00ae (canakinumab) for injection, for subcutaneous use n.d.\u00a0\u2013\u00a0FDA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/BLA125319_858687lbl.pdf."},{"key":"10.1016\/j.gofs.2024.04.004_bib0240","doi-asserted-by":"crossref","first-page":"P28","DOI":"10.1186\/1546-0096-13-S1-P28","article-title":"IL-1\u00a0inhibition in Muckle-Wells-Syndrome: withdrawal resulting in rapid deterioration of hearing loss","volume":"13","author":"Hansmann","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.gofs.2024.04.004_bib0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5152\/eurjrheum.2017.16075","article-title":"Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility","volume":"4","author":"Ilgen","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0250","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cjca.2022.10.020","article-title":"Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis","volume":"39","author":"Negro","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0255","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1093\/rheumatology\/keac177","article-title":"Safety of canakinumab during pregnancy: seven new cases","volume":"61","author":"Weber","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.gofs.2024.04.004_bib0260","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key075.245","article-title":"021\u00a0Canakinumab use during pregnancy for the treatment of systemic onset juvenile idiopathic arthritis and refractory macrophage activation syndrome","volume":"57","author":"Gunn","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.gofs.2024.04.004_bib0265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10067-022-06060-y","article-title":"Fetal exposure to canakinumab: a report of three pregnancies","volume":"41","author":"Ilgen","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-11-S2-O13","article-title":"PReS-FINAL-2178: Clinical and microarray follow-up of SJIA patients treated with anakinra over the past 10 years in a single institution","volume":"11","author":"Punaro","year":"2013","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.reprotox.2019.05.029","article-title":"#20\u00a0Anakinra use during pregnancy and lactation: A case report","volume":"88","author":"Duman","year":"2019","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40744-021-00313-z","article-title":"Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants","volume":"8","author":"Bosshard","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.gofs.2024.04.004_bib0285","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/art.38811","article-title":"Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin-Associated Periodic Syndromes","volume":"66","author":"Chang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0290","doi-asserted-by":"crossref","first-page":"P124","DOI":"10.1186\/1546-0096-13-S1-P124","article-title":"How safe it is to treat pregnant FMF patients with Anakinra?","volume":"13","author":"Ozdogan","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0295","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/key093","article-title":"Five successful pregnancies with antenatal anakinra exposure","volume":"57","author":"Smith","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.gofs.2024.04.004_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00393-017-0354-9","article-title":"IL-1-Blockade mit Anakinra in der Schwangerschaft","volume":"77","author":"Venhoff","year":"2018","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0305","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1\u00a0inhibitors","volume":"56","author":"Youngstein","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.gofs.2024.04.004_bib0310","doi-asserted-by":"crossref","first-page":"104583","DOI":"10.1016\/j.phrs.2019.104583","article-title":"Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives","volume":"152","author":"De Lorenzo","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.gofs.2024.04.004_bib0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RHU.0000000000000873","article-title":"Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study","volume":"26","author":"Babaoglu","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0320","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.gofs.2024.04.004_bib0325","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gofs.2024.04.004_bib0330","unstructured":"Le CRAT\u00a0\u2013\u00a0anakinra n.d. https:\/\/www.lecrat.fr\/10818 (accessed January 30, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0335","unstructured":"Le CRAT\u00a0\u2013\u00a0canakinumab n.d. https:\/\/www.lecrat.fr\/13470\/ (accessed January 30, 2024)."},{"key":"10.1016\/j.gofs.2024.04.004_bib0340","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1136\/ard.2008.105833","article-title":"A patient's wish: anakinra in pregnancy","volume":"68","author":"Berger","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gofs.2024.04.004_bib0345","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2009.126185","article-title":"Variable expression and treatment of PAPA syndrome","volume":"70","author":"Schellevis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gofs.2024.04.004_bib0175","first-page":"1021","article-title":"Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1\u00a0receptor antagonist (anakinra)","volume":"29","author":"Fischer-Betz","year":"2011","journal-title":"Clin Exp Rheumatol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718924001946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718924001946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T22:17:58Z","timestamp":1730585878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718924001946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2468718924001946"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2024.04.004","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tat des lieux sur les anti-IL-1\u00a0chez la femme enceinte","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}